← Leaderboards
Michail A Alterman
University Of Kansas Lawrence
$565,338
Attributed
$565,338
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $162.4K · FY2005–08$200K$150K$100K$50K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$565,338 · 4
By mechanism
P20$565,338 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Kansas Lawrence
Same institution · by research overlap
- Susan M Lunte$16,458,643
- Craig E Lunte$4,867,667
- Robert Scott Martin$2,229,701
- Rebecca Jean Whelan$1,679,630
- Robert P Hanzlik$12,359,909
Others in their field
Top investigators on “Biomedical Facility”
- David Heimbrook · Leidos Biomedical Research, Inc.$269,207,281
- Mark S Klempner · Tufts Medical Center$133,377,807
- Joseph E Robertson · Oregon Health & Science University$129,896,064
- Lee Hamm · Tulane University Of Louisiana$114,986,978
- Peter Gordon Gillespie · Oregon Health And Science University$108,298,240
- Jeffrey S Flier · Beth Israel Deaconess Medical Center$90,163,926
Research focus
Biomedical FacilitySurface Plasmon ResonanceProtein PurificationProteinsBiologicalBlood CapillariesCapillary, UnspecifiedCenters Of Research ExcellenceChemistryChromatography, High Pressure LiquidClinical ResearchComputer Retrieval Of Information On Scientific Projects DatabaseDoctor Of PhilosophyElectrophoresisFundingGrantHealth Services ResearchHigh Throughput ScreeningHousingInstitutionIsoelectric FocusingKansasLaboratoriesLigands
Grant awards (5)
COBRE: U KS: CORE C: PROTEIN PURIFICATION GROUP$124,393
P20 · FY2008 · RR · contact PI
COBRE: U KS: CORE C: PROTEIN PURIFICATION GROUP$130,001
P20 · FY2006 · RR · contact PI
COBRE: U KS: CORE C: PROTEIN PURIFICATION GROUP$162,361
P20 · FY2005 · RR
COBRE: U KS: CORE C: PROTEIN CHEMISTRY AND ANALYSIS LABORATORY$148,583
P20 · FY2004 · RR
Core--Protein chemistry and analysis$0
P20 · FY2002 · RR